In the modern American business culture, it is all too common to find people in positions of leadership they are not prepared for, or to be discouraged at the inexperience of a leadership team. Scott Rocklage stands above the rest; here are five reasons why.
1.) Leadership- He has unparalleled experience in the medical research and venture capital field- With over 30 years of leadership experience as President, Chairman of the Board, CEO, co-founder and trustee at the Nation’s top medical and venture capital companies, Dr. Rocklage has proven his ability to lead any team and work with executives and staff alike.
2.) Education- His PhD was obtained from MIT and Bachelors of Science in Chemistry from the University of California. MIT is world renown for excellent in scientific education and challenges all students to reach success- a value clearly seen in Scott Rocklage’s life and learn more about Scott.
3.) A track record of success- Throughout his lifetime Dr. Rocklage has been responsible positions through trials and approval process crucial to bringing FDA approval of three new drugs, and is inventor or co-inventor of over 300 U.S. patents and Scott’s lacrosse camp.
4.) Collaboration- During his career, companies including Cubist Pharmaceuticals, Nycomed Salutar, Relypsa and Catalytica have all listed Dr. Rocklage among their leadership team. In 2003 he joined 5AM Ventures as a Venture Partner and became a Managing Partner in 2004. He also currently serves as Board Chairman of Rennovia, Kinestral and Cidara. Furthermore, he also on the boards of Epirus and Pulmatrix and his Linkedin.
5.) A giving spirit- Dr. Rockladge was recently praised by MIT for his giving to the renovation of the Lester Wolfe Professor of Chemistry and Moungi Bawendi’s nanochemistry and nanotechnology labs. Rocklage stated he was honored to help with the needs of a noble-winning educational environment that he is proud to be part of.
5AM Ventures is truly thankful to have someone who is an innovator with a track record of getting results be part of the team. His knowledge of the medical industry gives him a unique perspective at understanding the venture capital market surrounding medical advancement and more information click here.
Although he is still in his twenties, Billy McFarland has been an entrepreneur for over a decade. He started his first business at the age of 12. Since then, McFarland has cleared his own unique path to success.
McFarland dropped out of college in order to found Spling, a tech company that counts Discovery and Universal among its clients. Spling transforms URLs from text links to images. This allows something more inviting to be posted on social media. McFarland continues to serve as CEO of Spling.
In 2013 Billy McFarland started perhaps his most ambitious project yet. Magnises is a black card aimed at millenials. As a successful businessman, McFarland moved in a world where black cards were common. He noticed, however, that the perks associated with these cards were geared more towards middle-aged people.
According to Crunchbase, Billy McFarland understood that young people wanted social perks more than they wanted air miles or hotel discounts. Benefits linked to the card include things like personal trainers, and membership at a club. Magnises has over 50 partnerships with companies that help it provide perks to users.
Magnises, however, is not a credit card. Rather, it takes data from a credit card the user already has. It transfers the data to the Magnises card. The original, actual credit card continues to work, too.
Currently, Magnises requires a $250 annual fee, and over 10,000 members. Magnises launched in New York, and has since expanded to Washington, DC. There are plans to launch the card in Los Angeles, Atlanta, London, Chicago, and other cities.
With such a track record of success at such a young age, it will be interesting to see what McFarland turns his attention to next. So far, he has been a fountain of great and highly marketable ideas.